ScoreWhy is HCW Biologics Inc. ?
1
With a growth in Net Sales of 24124.37%, the company declared Outstanding results in Mar 26
- NET SALES(HY) At USD 6.57 MM has Grown at 1,543.04%
- OPERATING CASH FLOW(Y) Highest at USD -11.46 MM
- RAW MATERIAL COST(Y) Fallen by -101.17% (YoY)
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to HCW Biologics Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is HCW Biologics Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
HCW Biologics Inc.
-93.17%
0.11
588.26%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-73.40%
EBIT Growth (5y)
6.11%
EBIT to Interest (avg)
-14.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.50
Sales to Capital Employed (avg)
0.37
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
33.87%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.09
EV to EBIT
-0.60
EV to EBITDA
-0.68
EV to Capital Employed
2.22
EV to Sales
8.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-369.76%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
NET SALES(HY)
At USD 6.57 MM has Grown at 1,543.04%
OPERATING CASH FLOW(Y)
Highest at USD -11.46 MM
RAW MATERIAL COST(Y)
Fallen by -101.17% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 81.22 times
OPERATING PROFIT(Q)
Highest at USD 3.38 MM
PRE-TAX PROFIT(Q)
Highest at USD 3.14 MM
NET PROFIT(Q)
Highest at USD 1.38 MM
EPS(Q)
Highest at USD 2.19
-1What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 92.81 %
Here's what is working for HCW Biologics Inc.
Net Sales
At USD 6.57 MM has Grown at 1,543.04%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 3.14 MM has Grown at 188.67%
over average net sales of the previous four periods of USD -3.54 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Operating Cash Flow
Highest at USD -11.46 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
At USD 1.38 MM has Grown at 119.37%
over average net sales of the previous four periods of USD -7.13 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Profit
Highest at USD 3.38 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 3.14 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 1.38 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 2.19
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 81.22 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -101.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for HCW Biologics Inc.
Debt-Equity Ratio
Highest at 92.81 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
